Abbisko Therapeutics Co, Ltd
Clinical trials sponsored by Abbisko Therapeutics Co, Ltd, explained in plain language.
-
New drug aims to boost growth in kids with dwarfism
Disease control Not yet recruitingThis study tests a new medicine called ABSK061 in 110 children with achondroplasia (a common form of dwarfism). The goal is to see if it is safe and can help children grow taller. The study is open-label, meaning everyone knows they are getting the drug, and it will last for at l…
Phase: PHASE1, PHASE2 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated May 17, 2026 03:19 UTC
-
New drug duo targets hard-to-treat lung cancer mutation
Disease control Not yet recruitingThis study tests a combination of two experimental drugs, ABSK043 and glecirasib, in people with advanced non-small cell lung cancer that has a specific mutation called KRAS G12C. The goal is to see if the combination is safe and shrinks tumors. About 86 adults will take part in …
Phase: PHASE2 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated May 11, 2026 20:49 UTC